K

Kovai Medical Center & Hospital Ltd

KOVAI NSE

Key Fundamentals

MicrocapHospitalsHealthcare Services
Market Cap
₹6,654 Cr
Volatility
Moderate
P/E Ratio
25.69
EBITDA
₹137 Cr
Return on Equity
20.09%
Debt to Equity
0.31
Book Value
₹1,205.91
52W High
₹6,340
52W Low
₹5,275.5

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Kovai Medical Center & Hospital Ltd insights

29 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Company has delivered good profit growth of 26.0% CAGR over last 5 years

Growth Rate

Revenue Growth
11.69% ↗
Net Income Growth
-3.49% ↘
Cash Flow Change
-12.33% ↘
ROE
-21.77% ↘
ROCE
-30.17% ↘
EBITDA Margin (Avg.)
-6.60% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 42d ago
AI opinion · based on fundamentals
Risk medium

Kovai Medical Center & Hospital Ltd (KMCH) is a mid-cap healthcare company with a market cap of ₹6,631 Cr, trading at a PE of 27x. The company has delivered consistent profit growth of ~26% CAGR over 5 years on sales CAGR of 18%, with ROE steady around 20-21%. Revenue grew from ~₹906 Cr in FY22 to ~₹1,371 Cr in FY25, reflecting strong operational scaling across its 2,250-bed multi-location network.

Bull Case 8
  • Strong profit compounding at 26% CAGR over 5 years and 28% CAGR over 3 years, significantly outpacing revenue growth and indicating operating leverage
  • Consistent ROE of 20-21% over 3, 5, and 10-year periods demonstrates efficient capital deployment and stable return generation
  • Revenue scaled from ₹906 Cr in FY22 to ₹1,371 Cr in FY25, a compounded sales growth of 16% over 3 years with TTM growth also at 16%
  • Large bed capacity of 2,250 beds across multiple locations in Southern India provides scale advantages and diversification of patient base
  • Operating profit grew from ₹268 Cr in FY23 to ₹386 Cr in FY25, implying operating margin expansion from ~26% to ~28%
  • Long 10-year track record of 13% sales CAGR and 20% profit CAGR shows resilience across economic cycles including COVID-19
  • Stock CAGR of 34% over 5 years and 24% over 10 years reflects sustained long-term value creation for shareholders
  • Chennai OMR property acquisition in August 2024 signals geographic expansion into India's largest metro healthcare market
Bear Case 8
  • PE ratio of 27x is elevated for a regional hospital chain with 16% revenue growth, leaving limited room for execution misses
  • Price-to-book ratio of 5.01x is high, suggesting the stock prices in significant future growth beyond current fundamentals
  • Potential capitalization of interest costs may overstate reported profits and asset values, raising accounting quality concerns
  • Dividend yield of just 0.17% indicates minimal cash return to shareholders despite healthy profitability
  • Stock returned -1% over the past 1 year despite 17% TTM profit growth, suggesting the market may be pricing in deceleration
  • Debt-to-equity ratio of 0.31x, while manageable, combined with potential interest capitalization means actual debt servicing burden may be understated
  • Concentration in Southern India (primarily Coimbatore) exposes the company to regional competitive and regulatory risks
  • Expansion into new geographies like Chennai requires heavy capex and carries execution risk with uncertain timelines for return on investment

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 42d ago
Headwinds 1
  • Joint MD passes away Jun 7

    Dr. Thavamani Devi Palaniswami, Joint Managing Director and promoter, passed away on June 6, 2026. She ceased to be a director and promoter, creating a leadership gap at the top.

Neutral 1
  • Trading window closed July 1 Jun 20

    KMCH closes trading window from July 1 until 48 hours after Q1FY27 results declaration, a routine pre-results compliance measure.

TL;DR: Kovai Medical Center faces a significant leadership transition following the passing of Joint MD Dr. Thavamani Devi Palaniswami on June 6. No positive catalysts emerged in the recent news cycle. The upcoming Q1FY27 results will be key to watch for operational continuity, and investors should monitor how the company manages succession and governance going forward.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
275
303
321
321
315
344
355
357
374
392
407
414
431
Expenses
206
217
225
229
229
248
252
256
268
285
291
303
307
Operating Profit
68
85
96
92
86
96
103
101
106
107
116
111
124
OPM %
25%
28%
30%
29%
27%
28%
29%
28%
28%
27%
28%
27%
29%
Other Income
6
4
5
6
5
5
6
6
6
6
7
8
7
Interest
10
8
7
7
7
8
9
9
9
9
8
6
8
Depreciation
22
23
23
24
24
24
25
25
26
27
28
29
32
PBT
42
58
71
67
61
67
75
74
76
78
87
84
92
Tax %
26%
26%
25%
22%
25%
25%
23%
26%
25%
24%
25%
25%
25%
Net Profit
31
43
53
52
46
51
58
55
57
59
65
63
69
EPS in Rs
28.38
39.67
48.53
47.69
41.81
46.32
52.82
49.99
52.3
53.79
59.42
57.89
63.14
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
402
465
531
588
628
712
690
905
1,020
1,220
1,371
1,586
1,644
Expenses
307
374
406
459
494
540
495
645
746
874
981
1,141
1,186
Operating Profit
94
92
125
129
135
171
195
261
274
346
390
445
458
OPM %
23%
20%
23%
22%
21%
24%
28%
29%
27%
28%
28%
28%
28%
Other Income
7
8
6
7
8
10
12
12
14
21
21
26
29
Interest
20
17
15
13
15
18
33
46
43
37
36
36
31
Depreciation
21
21
24
34
36
52
68
85
89
92
98
109
115
PBT
59
62
92
89
93
112
106
141
155
238
278
326
341
Tax %
35%
35%
35%
35%
35%
15%
27%
26%
25%
24%
25%
25%
—
Net Profit
39
40
60
58
60
95
78
104
116
180
209
244
256
EPS in Rs
35.37
36.95
54.81
52.99
54.96
86.44
71
95.28
106
164
191
223
234
Div. Payout %
4%
7%
5%
6%
5%
3%
4%
6%
9%
6%
5%
7%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
11
11
11
11
11
11
11
11
11
11
11
11
Reserves
127
165
224
276
332
420
499
598
708
878
1,075
1,308
Borrowings
163
158
125
202
378
543
623
550
511
310
415
403
Other Liabilities
85
96
103
116
129
134
148
184
209
240
299
345
Total Liabilities
386
430
464
605
850
1,108
1,281
1,343
1,439
1,439
1,801
2,067
Fixed Assets
281
337
354
443
469
643
1,033
1,085
1,088
1,118
1,283
1,474
CWIP
17
10
6
13
227
300
45
5
23
39
154
135
Investments
4
4
4
0
0
0
0
0
0
0
0
1
Other Assets
85
78
100
149
153
165
203
253
328
282
364
458
Total Assets
386
430
464
605
850
1,108
1,281
1,343
1,439
1,439
1,801
2,067
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
97
85
99
87
126
166
186
262
263
344
335
362
Investing
-80
-113
-83
-192
-352
-349
-180
-292
-358
-290
-593
-514
Financing
-43
-24
-50
60
160
113
38
-119
-86
-243
62
-58
Net Cash Flow
-26
-53
-33
-45
-66
-70
44
-149
-180
-189
-197
-210
Free Cash Flow
60
14
63
-41
-151
-102
5
163
136
206
-18
111
CFO/OP
119
109
99
92
117
115
106
115
110
116
101
100
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
9
7
8
8
6
4
7
8
8
5
8
9
Inventory Days
25
22
20
23
20
23
19
19
18
17
15
17
Days Payable
53
47
37
43
47
46
29
20
35
30
27
20
Cash Conversion Cycle
-19
-19
-9
-12
-21
-19
-2
6
-9
-7
-4
6
Working Capital Days
-60
-56
-50
-48
-55
-39
-56
-49
-48
-49
-57
-58
ROCE %
27%
25%
31%
24%
18%
15%
13%
16%
17%
23%
23%
23%

Shareholding Pattern

As of Jun 2026
Promoters 56.52%
Public 22.83%
Others 15.15%
DIIs 4.25%
FIIs 1.25%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
55.76%
55.76%
55.74%
55.74%
55.71%
55.76%
55.76%
55.76%
55.97%
56.26%
56.43%
56.43%
56.46%
56.49%
56.51%
56.55%
56.55%
56.55%
56.52%
56.52%
56.52%
56.52%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.25%
0.00%
0.34%
0.32%
0.45%
0.56%
1.10%
1.28%
1.24%
1.31%
1.20%
1.25%
DIIs
0.82%
1.43%
1.72%
1.77%
1.95%
1.95%
1.92%
1.97%
2.06%
1.92%
2.08%
1.92%
4.18%
4.29%
4.37%
4.43%
4.03%
4.52%
4.90%
4.73%
4.48%
4.25%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
21.93%
22.48%
22.30%
22.14%
21.73%
21.52%
21.45%
21.66%
21.81%
21.98%
21.81%
21.80%
22.20%
22.23%
22.30%
22.30%
22.25%
22.47%
22.55%
22.34%
22.62%
22.83%
Others
21.50%
20.33%
20.23%
20.35%
20.61%
20.77%
20.87%
20.62%
20.16%
19.84%
17.43%
19.85%
16.81%
16.67%
16.38%
16.17%
16.07%
15.18%
14.78%
15.11%
15.18%
15.15%
No. of Shareholders
7,771
10,076
9,951
9,517
9,688
9,559
9,530
9,464
9,674
10,487
10,730
10,338
11,918
13,147
14,800
15,951
17,086
17,650
18,681
18,644
18,864
19,362

Documents

Frequently Asked Questions about Kovai Medical Center & Hospital Ltd

What does Kovai Medical Center & Hospital Ltd do?
Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]
Where is Kovai Medical Center & Hospital Ltd (KOVAI) listed?
Kovai Medical Center & Hospital Ltd is listed on the Indian stock exchanges. It is listed on NSE: KOVAI and BSE: 523323. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Kovai Medical Center & Hospital Ltd belong to?
Kovai Medical Center & Hospital Ltd operates in the Healthcare Services sector within the Hospitals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Kovai Medical Center & Hospital Ltd?
Kovai Medical Center & Hospital Ltd has a market capitalisation of approximately ₹6653.99 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Kovai Medical Center & Hospital Ltd?
The Price-to-Earnings (PE) ratio of Kovai Medical Center & Hospital Ltd is 25.69. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Kovai Medical Center & Hospital Ltd?
Over the past 52 weeks, Kovai Medical Center & Hospital Ltd has traded between a low of ₹5,275.5 and a high of ₹6,340. This range helps investors understand the stock's price volatility and recent trading levels.
Does Kovai Medical Center & Hospital Ltd pay dividends?
Yes, Kovai Medical Center & Hospital Ltd has a dividend yield of 0.25%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Kovai Medical Center & Hospital Ltd?
Kovai Medical Center & Hospital Ltd has a Return on Equity (ROE) of 20.09%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Kovai Medical Center & Hospital Ltd on Tapetide?
On Tapetide, you can view Kovai Medical Center & Hospital Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Website kmchhospitals.com
CEO Dr. Nalla G. Palaniswami AB(USA), M.D.
Employees 5,992
Listed 2004-12-17
Face Value ₹ 10

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List